Evolution of ER-cut-off definition in clinical trials for triple negative breast cancer: trends and patterns over 15 years
Giorgio Bonomi, Davide Napetti, Gaia Griguolo, Francesca Zanghì, Fabio Girardi, Stefania Lando, Pietro Napolitano, Giusy Landa, Marina La Commare, Davide Massa, Valentina Guarneri, Maria Vittoria Dieci · 2026
Read Evolution of ER-cut-off definition in clinical trials for triple negative breast cancer: trends and patterns over 15 years by Giorgio Bonomi, Davide Napetti, Gaia Griguolo, Francesca Zanghì, Fabio Girardi, Stefania Lando, Pietro Napolitano, Giusy Landa, Marina La Commare, Davide Massa, Valentina Guarneri, Maria Vittoria Dieci (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218251.txt.
Description
Bonomi and ten co-authors track how breast cancer trials set a key entry bar over fifteen years in this twenty twenty-six study. One harsh breast type is set by low marks on two tests, but some low-mark tumors act much like it. Who gets into a trial turns on where that low bar is drawn.
Inside, the team searched a large trial list and kept six hundred twenty trials that fit the theme. Most trials barred the low-mark group, though the share that let them in rose over time. Top-stage and firm-backed trials let them in least, while local-team trials let them in more. The authors urge a wider bar so those patients can reach new drugs.
Catalog record
| CREATOR | Giorgio Bonomi, Davide Napetti, Gaia Griguolo, Francesca Zanghì, Fabio Girardi, Stefania Lando, Pietro Napolitano, Giusy Landa, Marina La Commare, Davide Massa, Valentina Guarneri, Maria Vittoria Dieci |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |